Absci(ABSI.US)

Last Updated 19:00:00 ET
longbridge loading

HC Wainwright Has Optimistic Outlook of Absci Q3 Earnings

Market Beat·
US
ABSI
+6.91%
Market Beat·
US
ABSI
+6.91%

AbSci (ABSI) Receives a Rating Update from a Top Analyst

Tip Ranks·
US
ABSI
+6.91%
US
LABU
+11.76%
US
PBE
+1.60%
Tip Ranks·
US
ABSI
+6.91%
US
LABU
+11.76%
US
PBE
+1.60%

AbSci Price Target Raised to $11 as Analyst Reiterates Buy on Promising PRLR Pipeline and ABS-201 Data

Tip Ranks·
US
ABSI
+6.91%
US
SBIO
+3.75%
US
PBE
+1.60%
Tip Ranks·
US
ABSI
+6.91%
US
SBIO
+3.75%
US
PBE
+1.60%

Absci Corp. Charts High-Stakes Path With ABS-201

Tip Ranks·
US
ABSI
+6.91%
US
IBBQ
+2.43%
US
BBH
+0.96%
Tip Ranks·
US
ABSI
+6.91%
US
IBBQ
+2.43%
US
BBH
+0.96%

12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga_article·
US
INM
+0.63%
US
AMLX
+6.83%
US
SRTS
-0.90%
benzinga_article·
US
INM
+0.63%
US
AMLX
+6.83%
US
SRTS
-0.90%

Absci shares are trading lower after the company reported mixed Q1 financial results.

benzinga_article·
US
ABSI
+6.91%
benzinga_article·
US
ABSI
+6.91%

Brendan Smith Reiterates Buy on AbSci, Citing Emerging PRLR Franchise and Multiple Upcoming Clinical Catalysts

Tip Ranks·
US
ABSI
+6.91%
US
XBI
+3.88%
US
IBBQ
+2.43%
Tip Ranks·
US
ABSI
+6.91%
US
XBI
+3.88%
US
IBBQ
+2.43%

Absci | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 215 K

Earnings Watch·
US
ABSI
+6.91%
Earnings Watch·
US
ABSI
+6.91%

Absci | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 215 K

Earnings Watch·
US
ABSI
+6.91%
Earnings Watch·
US
ABSI
+6.91%
© 2026 Longbridge｜Disclaimer